| 51 |
19838098 | Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial. | 2010 Jan 2 |
3 |
| 52 |
20130569 | ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. | 2010 May |
3 |
| 53 |
20195400 | Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia. | 2010 Mar |
1 |
| 54 |
20335146 | [Effects of rosuvastatin on left ventricular cardiac function, arteriosclerotic plaque and high sensitive C-reactive protein in hypertensive patients with mild LDL-C elevation]. | 2010 Mar |
3 |
| 55 |
20679960 | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 2010 Oct |
1 |
| 56 |
20953684 | Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study. | 2010 Dec |
1 |
| 57 |
21090830 | The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices. | 2010 |
2 |
| 58 |
21090831 | Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels. | 2010 |
3 |
| 59 |
21122696 | Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients. | 2010 Nov-Dec |
2 |
| 60 |
22291492 | A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy. | 2010 |
1 |
| 61 |
18996523 | Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study. | 2009 May |
2 |
| 62 |
19174696 | Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin. | 2009 Apr |
1 |
| 63 |
19729865 | Effects of rosuvastatin on low-density lipoprotein cholesterol and plasma lipids in Asian patients with hypercholesterolemia. | 2009 Aug |
5 |
| 64 |
19745745 | A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. | 2009 Dec |
2 |
| 65 |
19916726 | Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice. | 2009 Dec |
8 |
| 66 |
19997842 | [Achievement of blood lipid target levels with Ezetimibe/Simvastatin in patients with atherosclerosis and/or diabetes mellitus--an Austrian observational study]. | 2009 |
1 |
| 67 |
23555375 | A Randomized Controlled Study to Compare the Effects of Rosuvastatin 2.5 mg and Pravastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-1). | 2009 |
3 |
| 68 |
23555376 | A Randomized Controlled Study to Compare the Effects of Rosuvastatin 5 mg and Atorvastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-2). | 2009 |
2 |
| 69 |
18364261 | Efficacy and safety of rosuvastatin in Taiwanese patients. | 2008 Mar |
1 |
| 70 |
18434729 | Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. | 2008 |
4 |
| 71 |
18489494 | Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. | 2008 Dec |
4 |
| 72 |
18578957 | LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results. | 2008 Aug |
2 |
| 73 |
18654867 | Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia. | 2008 Jul 26 |
1 |
| 74 |
18690760 | Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia. | 2008 |
4 |
| 75 |
21291725 | Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses. | 2008 Apr |
4 |
| 76 |
21291777 | Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein. | 2008 Dec |
1 |
| 77 |
17484092 | [Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)]. | 2007 Apr |
3 |
| 78 |
17655813 | Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. | 2007 Sep |
7 |
| 79 |
17996658 | Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. | 2007 Sep |
5 |
| 80 |
18158079 | Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. | 2007 Nov |
5 |
| 81 |
21291692 | Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia. | 2007 Aug |
2 |
| 82 |
16533939 | Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. | 2006 Apr 5 |
1 |
| 83 |
16644314 | Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II. | 2006 May |
3 |
| 84 |
17112329 | Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. | 2006 Nov |
4 |
| 85 |
17212997 | Expanding options with a wider range of rosuvastatin doses. | 2006 Nov |
3 |
| 86 |
15707472 | Review of efficacy of rosuvastatin 5 mg. | 2005 Jan |
4 |
| 87 |
16128507 | Rosuvastatin: a high-potency HMG-CoA reductase inhibitor. | 2005 Jul-Aug |
2 |
| 88 |
16143705 | A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study. | 2005 Dec |
4 |
| 89 |
16186052 | Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals. | 2005 Oct 10 |
6 |
| 90 |
15161326 | Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. | 2004 |
2 |
| 91 |
15215813 | Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial. | 2004 Jul |
5 |
| 92 |
15531000 | Rosuvastatin in the management of hyperlipidemia. | 2004 Sep |
6 |
| 93 |
15639694 | Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. | 2004 Nov |
4 |
| 94 |
16035394 | A review of the efficacy of rosuvastatin in patients with type 2 diabetes. | 2004 Oct |
3 |
| 95 |
19667621 | New evidence supporting aggressive lipid lowering. | 2003 Apr |
1 |
| 96 |
11900720 | Managing dyslipidemia in the high-risk patient. | 2002 Mar 7 |
2 |
| 97 |
12137448 | Statin therapy: rationale for a new agent, rosuvastatin. | 2002 Jun |
3 |
| 98 |
12238638 | Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study. | 2002 |
1 |
| 99 |
12486415 | Management of dyslipidemia in the high-risk patient. | 2002 Dec |
2 |
| 100 |
11256849 | Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin Rosuvastatin. | 2001 Mar 8 |
2 |